The Scientist

» clinical trials and developmental biology

Most Recent

image: Opinion: How HIV Became Positive

Opinion: How HIV Became Positive

By | September 17, 2013

Immunotherapies, such as the re-engineered T cells that last year saved a 7-year-old girl’s life, continue to show promise as cancer treatments.

1 Comment

image: Opinion: Translational Research in Crisis

Opinion: Translational Research in Crisis

By | September 10, 2013

Turning discoveries made in academic labs into innovative therapies requires a radically new approach.

2 Comments

image: Ovarian Cancer Screen Shows Promise

Ovarian Cancer Screen Shows Promise

By | August 27, 2013

A blood test for the protein CA-125, coupled with a vaginal ultrasound, can help detect the difficult-to-spot cancer.

0 Comments

image: Bacterial Quid Pro Quo

Bacterial Quid Pro Quo

By | August 19, 2013

Pseudomonas aeruginosa gather swarming speed at the expense of their ability to form biofilms in an experimental evolution setup.

0 Comments

image: Stem Cells Open Up Options

Stem Cells Open Up Options

By | August 13, 2013

Pluripotent cells can help regenerate tissues and maintain long life—and they may also help animals jumpstart drastically new lifestyles.

17 Comments

image: Preliminary Malaria Vaccine Trial a Success

Preliminary Malaria Vaccine Trial a Success

By | August 9, 2013

An intravenous vaccine appears to protect adults from malaria infection in a Phase 1 clinical trial.

0 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: First Ever iPS-Cell Trial a Go

First Ever iPS-Cell Trial a Go

By | July 22, 2013

The Japanese government will allow a study of stem cell therapy using patients’ own cells, reprogrammed to be stem cells, to treat vision loss.

1 Comment

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Infant Microbiome: Vaginal Delivery Versus C-Section
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Opinion: WHO’s Silence on Cannabis
Rockland